NeuroEM Therapeutics key facts
as of Oct 2026- Developer of a medical device system designed to combat cognitive impairment caused by neurodegenerative conditions.
- NeuroEM Therapeutics is valued at approximately $17.0M as of Oct 2026, set at its later-stage round, Aug 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $6.2M across 2 recorded rounds; the latest was Seed Round ($1.9M) in Apr 2025.
- Notable investors include National Institutes of Health, Tampa Bay Wave, New York Angels, BlueLake Ventures, Lunch Pail Ventures — 8 tracked in total.
- NeuroEM Therapeutics has filed 2 Form Ds with the SEC since 2024, most recently Apr 2025 ($1.9M sold to 23 investors).
- Status: Privately Held (backing).
Valued at $17.0M at its later-stage round, Aug 2025. Nothing has traded since.
- ·Watch NeuroEM Therapeutics: the Monday email on marks, rounds and moves
NeuroEM Therapeutics funding rounds
2 roundsNeuroEM Therapeutics valuation
NeuroEM Therapeutics was valued at $17 million at its later-stage round in Aug 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has NeuroEM Therapeutics raised?
NeuroEM Therapeutics has raised $6.2 million in total; 2 of its rounds are on record. The largest on record was a $360,000 seed round in May 2024; the most recent was a $1.9 million seed round in Apr 2025.
NeuroEM Therapeutics has filed 2 Form Ds with the SEC since 2024, most recently in Apr 2025 ($1.9 million sold to 23 investors).
NeuroEM Therapeutics investors
8 investors are on record for NeuroEM Therapeutics, including National Institutes of Health, Tampa Bay Wave, New York Angels and BlueLake Ventures. The seed round in Apr 2025 drew 23 investors.
About NeuroEM Therapeutics
Developer of a medical device system designed to combat cognitive impairment caused by neurodegenerative conditions. The company's device targets specific regions of the brain affected by Alzheimer's disease, breaking down beta-amyloid and p-tau proteins using transcranial electromagnetic treatment leveraging radio frequencies, enabling healthcare professionals to slow or potentially stop the progression of cognitive challenges.
- Sector
- Healthcare
- HQ
- Tampa, FL, United States
- Founded
- 2013
- Employees
- 6
- Website
- neuroem.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.